Table 1.
Year | Discovery | Investigator | Paradigm shift | Clinical Translation |
---|---|---|---|---|
Antiquity | First descriptions of cholera | |||
1817 | First global cholera pandemic | |||
1849 | Transmission of cholera by contaminated water | John Snow | Development of epidemiologic methodology | Epidemiologic research |
1854 | Discovery of cholera microor-ganisms | Filippo Pacini | Bacterial basis of epidemic diarrhea | Prevention of waterborne infectious diseases |
1832 | Intravenous hydration for severe cholera | Thomas Lata and others | Use of intravenous fluids for cholera treatment | Development of saline-based solutions for intravascular volume resuscitation |
1886 | Isolation and culture of Vibrio cholerce | Robert Kocha | Proving causality of infectious agents in disease | Foundations for the field of infectious diseases |
1959 | Discovery of cholera exotoxin | S. N. De | Luminal action of cholera toxin, discovery of enterotoxins | GC-C receptor ligands for functional bowel diseases and constipation |
1960 | Discovery of Na+:glucose cotransport | Robert Crane | Discovery of ion cotransport as a mechanism of active transport | SGLT2 inhibitors, targeting drug uptake |
1968 | Development of ORS | David R. Nalin and others | The efficacy of oral hydration for massive fluid losses | ORS and for epidemic diarrhea and Pedialyte® for pediatric diarrhea |
1971 | Induction of adenylate cyclase by cholera toxin | Michael Field and others | The discovery of the mechanism of toxin-induced fluid secretion | GC-C receptor ligands for functional bowel diseases and constipation |
Recipient of the Nobel Prize for Physiology and Medicine in 1905 for studies related to M. tuberculosis